Axonal T3 uptake and transport can trigger thyroid hormone signaling in the brain

  1. Federico Salas-Lucia
  2. Csaba Fekete
  3. Richárd Sinko
  4. Péter Egri
  5. Kristóf Rada
  6. Yvette Ruska
  7. Balázs Gereben  Is a corresponding author
  8. Antonio Bianco  Is a corresponding author
  1. University of Chicago Medical Center, United States
  2. Institute of Experimental Medicine, Hungary
  3. University of Chicago, United States

Abstract

The development of the brain, as well as mood and cognitive functions, are affected by thyroid hormone (TH) signaling. Neurons are the critical cellular target for TH action, with T3 regulating the expression of important neuronal gene sets. However, the steps involved in T3 signaling remain poorly known given that neurons express high levels of type 3 deiodinase (D3), which inactivates both T4 and T3. To investigate this mechanism, we used a compartmentalized microfluid device and identified a novel neuronal pathway of T3 transport and action that involves axonal T3 uptake into clathrin-dependent, endosomal/non-degradative lysosomes (NDLs). NDLs-containing T3 are retrogradely transported via microtubules, delivering T3 to the cell nucleus, and doubling the expression of a T3-responsive reporter gene. The NDLs also contain the monocarboxylate transporter 8 (Mct8) and D3, which transport and inactivate T3, respectively. Notwithstanding, T3 gets away from degradation because D3's active center is in the cytosol. Moreover, we used a unique mouse system to show that T3 implanted in specific brain areas can trigger selective signaling in distant locations, as far as the contralateral hemisphere. These findings provide a pathway for L-T3 to reach neurons and resolve the paradox of T3 signaling in the brain amid high D3 activity.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting file; Source Data files have been provided for supplementary figures 2

Article and author information

Author details

  1. Federico Salas-Lucia

    Section of Adult and Pediatric Endocrinology and Metabolism, University of Chicago Medical Center, Chicago, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4141-5790
  2. Csaba Fekete

    Laboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8206-562X
  3. Richárd Sinko

    Laboratory of Molecular Cell Metabolism, Institute of Experimental Medicine, Budapest, Hungary
    Competing interests
    No competing interests declared.
  4. Péter Egri

    Laboratory of Molecular Cell Metabolism, Institute of Experimental Medicine, Budapest, Hungary
    Competing interests
    No competing interests declared.
  5. Kristóf Rada

    Laboratory of Molecular Cell Metabolism, Institute of Experimental Medicine, Budapest, Hungary
    Competing interests
    No competing interests declared.
  6. Yvette Ruska

    Laboratory of Integrative Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary
    Competing interests
    No competing interests declared.
  7. Balázs Gereben

    Laboratory of Molecular Cell Metabolism, Institute of Experimental Medicine, Budapest, Hungary
    For correspondence
    gereben.balazs@koki.mta.hu
    Competing interests
    No competing interests declared.
  8. Antonio Bianco

    Section of Adult and Pediatric Endocrinology and Metabolism, University of Chicago, Chicago, United States
    For correspondence
    abianco1@uchicago.edu
    Competing interests
    Antonio Bianco, Consultant fees: AbbVie, Synthonics, Sention, Thyron, Accella.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7737-6813

Funding

The Hungarian National Brain Research Program 2 (NRDIO K125247)

  • Csaba Fekete

National Institute of Diabetes and Digestive and Kidney Diseases (DK58538)

  • Balázs Gereben

National Institute of Diabetes and Digestive and Kidney Diseases (DK58538,DK65055)

  • Antonio Bianco

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Rauf Latif, Icahn School of Medicine at Mount Sinai, United States

Ethics

Animal experimentation: All experiments were approved by the Institutional Animal Care and Use Committee at the University of Chicago (#72577) or by the Animal Welfare Committee at the Institute of ExperimentalMedicine and followed the American Thyroid Association Guide to investigating TH economy and action in rodents and cell models (52).

Version history

  1. Received: August 13, 2022
  2. Preprint posted: August 18, 2022 (view preprint)
  3. Accepted: May 18, 2023
  4. Accepted Manuscript published: May 19, 2023 (version 1)
  5. Version of Record published: June 5, 2023 (version 2)

Copyright

© 2023, Salas-Lucia et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 930
    views
  • 152
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Federico Salas-Lucia
  2. Csaba Fekete
  3. Richárd Sinko
  4. Péter Egri
  5. Kristóf Rada
  6. Yvette Ruska
  7. Balázs Gereben
  8. Antonio Bianco
(2023)
Axonal T3 uptake and transport can trigger thyroid hormone signaling in the brain
eLife 12:e82683.
https://doi.org/10.7554/eLife.82683

Share this article

https://doi.org/10.7554/eLife.82683

Further reading

    1. Medicine
    2. Neuroscience
    Matthew F Wipperman, Allen Z Lin ... Olivier Harari
    Tools and Resources

    Gait is impaired in musculoskeletal conditions, such as knee arthropathy. Gait analysis is used in clinical practice to inform diagnosis and to monitor disease progression or intervention response. However, clinical gait analysis relies on subjective visual observation of walking, as objective gait analysis has not been possible within clinical settings due to the expensive equipment, large-scale facilities, and highly trained staff required. Relatively low-cost wearable digital insoles may offer a solution to these challenges. In this work, we demonstrate how a digital insole measuring osteoarthritis-specific gait signatures yields similar results to the clinical gait-lab standard. To achieve this, we constructed a machine learning model, trained on force plate data collected in participants with knee arthropathy and controls. This model was highly predictive of force plate data from a validation set (area under the receiver operating characteristics curve [auROC] = 0.86; area under the precision-recall curve [auPR] = 0.90) and of a separate, independent digital insole dataset containing control and knee osteoarthritis subjects (auROC = 0.83; auPR = 0.86). After showing that digital insole derived gait characteristics are comparable to traditional gait measurements, we next showed that a single stride of raw sensor time series data could be accurately assigned to each subject, highlighting that individuals using digital insoles can be identified by their gait characteristics. This work provides a framework for a promising alternative to traditional clinical gait analysis methods, adds to the growing body of knowledge regarding wearable technology analytical pipelines, and supports clinical development of at-home gait assessments, with the potential to improve the ease, frequency, and depth of patient monitoring.

    1. Medicine
    Anika Shimonty, Fabrizio Pin ... Lynda F Bonewald
    Research Article

    Irisin, released from exercised muscle, has been shown to have beneficial effects on numerous tissues but its effects on bone are unclear. We found significant sex and genotype differences in bone from wildtype (WT) mice compared to mice lacking Fndc5 (knockout [KO]), with and without calcium deficiency. Despite their bone being indistinguishable from WT females, KO female mice were partially protected from osteocytic osteolysis and osteoclastic bone resorption when allowed to lactate or when placed on a low-calcium diet. Male KO mice have more but weaker bone compared to WT males, and when challenged with a low-calcium diet lost more bone than WT males. To begin to understand responsible molecular mechanisms, osteocyte transcriptomics was performed. Osteocytes from WT females had greater expression of genes associated with osteocytic osteolysis and osteoclastic bone resorption compared to WT males which had greater expression of genes associated with steroid and fatty acid metabolism. Few differences were observed between female KO and WT osteocytes, but with a low-calcium diet, the KO females had lower expression of genes responsible for osteocytic osteolysis and osteoclastic resorption than the WT females. Male KO osteocytes had lower expression of genes associated with steroid and fatty acid metabolism, but higher expression of genes associated with bone resorption compared to male WT. In conclusion, irisin plays a critical role in the development of the male but not the female skeleton and protects male but not female bone from calcium deficiency. We propose irisin ensures the survival of offspring by targeting the osteocyte to provide calcium in lactating females, a novel function for this myokine.